Contact
searchSearch
HMP Global

Pharmacy Learning Network

Featured

Ann Latner Headshot
Commentary
FTC Releases Second Interim Report on Prescription Drug Middlemen
03/27/2025
Ann W. Latner, JD
The Federal Trade Commission (FTC) published its second interim staff report on the prescription drug middlemen industry in early 2025. The report focuses on pharmacy benefits managers’ (PBMs’) influence over specialty generic drugs.
The Federal Trade Commission (FTC) published its second interim staff report on the prescription drug middlemen industry in early 2025. The report focuses on pharmacy benefits managers’ (PBMs’) influence over specialty generic drugs.
The Federal Trade Commission...
03/27/2025
Pharmacy Learning Network
News
FDA Issues a Class II Recall of Prasugrel Tablets
03/26/2025
Juliet Gallagher
Mylan Pharmaceuticals Inc. has issued a voluntary Class II recall of Prasugrel Tablets, USP, 5 mg after routine testing revealed low dissolution results, indicating that affected tablets may not dissolve properly in the body.
Mylan Pharmaceuticals Inc. has issued a voluntary Class II recall of Prasugrel Tablets, USP, 5 mg after routine testing revealed low dissolution results, indicating that affected tablets may not dissolve properly in the body.
Mylan Pharmaceuticals Inc. has...
03/26/2025
Pharmacy Learning Network
News
Amgen Recalls Multiple Lots of Neupogen Due to Potential Stability Concerns
03/26/2025
Juliet Gallagher
Amgen Inc. has initiated a voluntary Class II recall of several lots of Neupogen (filgrastim) for injection, including both the 300 mcg/1 mL and 480 mcg/1.6 mL (300 mcg/mL) formulations.
Amgen Inc. has initiated a voluntary Class II recall of several lots of Neupogen (filgrastim) for injection, including both the 300 mcg/1 mL and 480 mcg/1.6 mL (300 mcg/mL) formulations.
Amgen Inc. has initiated a...
03/26/2025
Pharmacy Learning Network
News
Vitality Male Enhancement Supplement Recalled Due to Undeclared Drug Ingredients
03/26/2025
Juliet Gallagher
One Source Nutrition, Inc. has voluntarily recalled its product Vitality, fast acting male enhancement, distributed as both single capsule packets and bottles containing 6 capsules, due to the presence of undeclared pharmaceutical ingredients.
One Source Nutrition, Inc. has voluntarily recalled its product Vitality, fast acting male enhancement, distributed as both single capsule packets and bottles containing 6 capsules, due to the presence of undeclared pharmaceutical ingredients.
One Source Nutrition, Inc. has...
03/26/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
New York Pharmacist Arrested for Illegal Dispensing
03/20/2025
Ann W. Latner, JD
The New York State Police have announced the arrest of pharmacist Clyde Stevens, 46, of Binghamton, NY following an investigation at a Rite Aid pharmacy in Endwell, NY.
The New York State Police have announced the arrest of pharmacist Clyde Stevens, 46, of Binghamton, NY following an investigation at a Rite Aid pharmacy in Endwell, NY.
The New York State Police have...
03/20/2025
Pharmacy Learning Network
News
ICU Medical Recalls Potassium Chloride Injection Due to Labeling Error
03/20/2025
Grace Taylor, MS, MA
ICU Medical, Inc has recalled potassium chloride injection (20 mEq in 100 mL) due to a labeling error that may misrepresent the product’s strength, posing a risk of dosing confusion.
ICU Medical, Inc has recalled potassium chloride injection (20 mEq in 100 mL) due to a labeling error that may misrepresent the product’s strength, posing a risk of dosing confusion.
ICU Medical, Inc has recalled...
03/20/2025
Pharmacy Learning Network
News
Breckenridge Pharmaceutical Recalls Duloxetine Capsules Due to Impurity Concerns
03/20/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has recalled Duloxetine Delayed-Release Capsules (60 mg) due to the presence of N-nitroso-duloxetine impurity exceeding US Food and Drug Administration limits.
Breckenridge Pharmaceutical has recalled Duloxetine Delayed-Release Capsules (60 mg) due to the presence of N-nitroso-duloxetine impurity exceeding US Food and Drug Administration limits.
Breckenridge Pharmaceutical has...
03/20/2025
Pharmacy Learning Network
News
Pitavastatin Tablets Recalled Due to Foreign Tablet Contamination
03/20/2025
Grace Taylor, MS, MA
A Class III recall has been initiated for Livalo (pitavastatin) tablets due to the presence of foreign tablets or capsules in the product.
A Class III recall has been initiated for Livalo (pitavastatin) tablets due to the presence of foreign tablets or capsules in the product.
A Class III recall has been...
03/20/2025
Pharmacy Learning Network
News
Study Finds RSV Positivity Not Linked to Higher Mortality in Adults With Acute Respiratory Illness
03/17/2025
Grace Taylor, MS, MA
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Kroger Agrees to Pay $110 Million to Resolve Kentucky Opioid Lawsuit
03/13/2025
Ann W. Latner, JD
Kentucky Attorney General Russell Coleman has announced a multimillion-dollar settlement in the state’s case against Kroger. The Case The state of Kentucky alleged that Kroger helped fuel a deadly opioid epidemic by flooding communities...
Kentucky Attorney General Russell Coleman has announced a multimillion-dollar settlement in the state’s case against Kroger. The Case The state of Kentucky alleged that Kroger helped fuel a deadly opioid epidemic by flooding communities...
Kentucky Attorney General...
03/13/2025
Pharmacy Learning Network
News
FDA Issues a Class II Recall of Ferrous Sulfate Oral Syringes
03/12/2025
Juliet Gallagher
Safecor Health, LLC has issued a voluntary nationwide recall of ferrous sulfate 7.5 mg iron/0.5 mL oral syringes due to a defective delivery system that may cause leakage after repackaging into unit-dose syringes.
Safecor Health, LLC has issued a voluntary nationwide recall of ferrous sulfate 7.5 mg iron/0.5 mL oral syringes due to a defective delivery system that may cause leakage after repackaging into unit-dose syringes.
Safecor Health, LLC has issued a...
03/12/2025
Pharmacy Learning Network

News

News
FDA Issues a Class II Recall of Prasugrel Tablets
03/26/2025
Juliet Gallagher
Mylan Pharmaceuticals Inc. has issued a voluntary Class II recall of Prasugrel Tablets, USP, 5 mg after routine testing revealed low dissolution results, indicating that affected tablets may not dissolve properly in the body.
Mylan Pharmaceuticals Inc. has issued a voluntary Class II recall of Prasugrel Tablets, USP, 5 mg after routine testing revealed low dissolution results, indicating that affected tablets may not dissolve properly in the body.
Mylan Pharmaceuticals Inc. has...
03/26/2025
Pharmacy Learning Network
News
Amgen Recalls Multiple Lots of Neupogen Due to Potential Stability Concerns
03/26/2025
Juliet Gallagher
Amgen Inc. has initiated a voluntary Class II recall of several lots of Neupogen (filgrastim) for injection, including both the 300 mcg/1 mL and 480 mcg/1.6 mL (300 mcg/mL) formulations.
Amgen Inc. has initiated a voluntary Class II recall of several lots of Neupogen (filgrastim) for injection, including both the 300 mcg/1 mL and 480 mcg/1.6 mL (300 mcg/mL) formulations.
Amgen Inc. has initiated a...
03/26/2025
Pharmacy Learning Network
News
Vitality Male Enhancement Supplement Recalled Due to Undeclared Drug Ingredients
03/26/2025
Juliet Gallagher
One Source Nutrition, Inc. has voluntarily recalled its product Vitality, fast acting male enhancement, distributed as both single capsule packets and bottles containing 6 capsules, due to the presence of undeclared pharmaceutical ingredients.
One Source Nutrition, Inc. has voluntarily recalled its product Vitality, fast acting male enhancement, distributed as both single capsule packets and bottles containing 6 capsules, due to the presence of undeclared pharmaceutical ingredients.
One Source Nutrition, Inc. has...
03/26/2025
Pharmacy Learning Network
News
ICU Medical Recalls Potassium Chloride Injection Due to Labeling Error
03/20/2025
Grace Taylor, MS, MA
ICU Medical, Inc has recalled potassium chloride injection (20 mEq in 100 mL) due to a labeling error that may misrepresent the product’s strength, posing a risk of dosing confusion.
ICU Medical, Inc has recalled potassium chloride injection (20 mEq in 100 mL) due to a labeling error that may misrepresent the product’s strength, posing a risk of dosing confusion.
ICU Medical, Inc has recalled...
03/20/2025
Pharmacy Learning Network
News
Breckenridge Pharmaceutical Recalls Duloxetine Capsules Due to Impurity Concerns
03/20/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has recalled Duloxetine Delayed-Release Capsules (60 mg) due to the presence of N-nitroso-duloxetine impurity exceeding US Food and Drug Administration limits.
Breckenridge Pharmaceutical has recalled Duloxetine Delayed-Release Capsules (60 mg) due to the presence of N-nitroso-duloxetine impurity exceeding US Food and Drug Administration limits.
Breckenridge Pharmaceutical has...
03/20/2025
Pharmacy Learning Network
News
Pitavastatin Tablets Recalled Due to Foreign Tablet Contamination
03/20/2025
Grace Taylor, MS, MA
A Class III recall has been initiated for Livalo (pitavastatin) tablets due to the presence of foreign tablets or capsules in the product.
A Class III recall has been initiated for Livalo (pitavastatin) tablets due to the presence of foreign tablets or capsules in the product.
A Class III recall has been...
03/20/2025
Pharmacy Learning Network
News
Study Finds RSV Positivity Not Linked to Higher Mortality in Adults With Acute Respiratory Illness
03/17/2025
Grace Taylor, MS, MA
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
FDA Issues a Class II Recall of Ferrous Sulfate Oral Syringes
03/12/2025
Juliet Gallagher
Safecor Health, LLC has issued a voluntary nationwide recall of ferrous sulfate 7.5 mg iron/0.5 mL oral syringes due to a defective delivery system that may cause leakage after repackaging into unit-dose syringes.
Safecor Health, LLC has issued a voluntary nationwide recall of ferrous sulfate 7.5 mg iron/0.5 mL oral syringes due to a defective delivery system that may cause leakage after repackaging into unit-dose syringes.
Safecor Health, LLC has issued a...
03/12/2025
Pharmacy Learning Network
News
Simethicone Oral Syringes Recalled Due to Leakage Issue
03/12/2025
Juliet Gallagher
Safecor Health, LLC has issued a voluntary nationwide recall of simethicone 20 mg per 0.3 mL oral syringes due to a defective delivery system that may cause leakage after the solution is repackaged into unit-dose syringes.
Safecor Health, LLC has issued a voluntary nationwide recall of simethicone 20 mg per 0.3 mL oral syringes due to a defective delivery system that may cause leakage after the solution is repackaged into unit-dose syringes.
Safecor Health, LLC has issued a...
03/12/2025
Pharmacy Learning Network
News
Nelarabine Injection Recalled Due to Impurity and Degradation Concerns
03/12/2025
Juliet Gallagher
Zydus Pharmaceuticals (USA) Inc. has issued a nationwide voluntary recall of nelarabine injection, 250 mg/50 mL (5 mg/mL), citing failed impurities and degradation specifications as the reason for withdrawal.
Zydus Pharmaceuticals (USA) Inc. has issued a nationwide voluntary recall of nelarabine injection, 250 mg/50 mL (5 mg/mL), citing failed impurities and degradation specifications as the reason for withdrawal.
Zydus Pharmaceuticals (USA) Inc....
03/12/2025
Pharmacy Learning Network

Commentary

Ann Latner Headshot
Commentary
FTC Releases Second Interim Report on Prescription Drug Middlemen
03/27/2025
Ann W. Latner, JD
The Federal Trade Commission (FTC) published its second interim staff report on the prescription drug middlemen industry in early 2025. The report focuses on pharmacy benefits managers’ (PBMs’) influence over specialty generic drugs.
The Federal Trade Commission (FTC) published its second interim staff report on the prescription drug middlemen industry in early 2025. The report focuses on pharmacy benefits managers’ (PBMs’) influence over specialty generic drugs.
The Federal Trade Commission...
03/27/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
New York Pharmacist Arrested for Illegal Dispensing
03/20/2025
Ann W. Latner, JD
The New York State Police have announced the arrest of pharmacist Clyde Stevens, 46, of Binghamton, NY following an investigation at a Rite Aid pharmacy in Endwell, NY.
The New York State Police have announced the arrest of pharmacist Clyde Stevens, 46, of Binghamton, NY following an investigation at a Rite Aid pharmacy in Endwell, NY.
The New York State Police have...
03/20/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Kroger Agrees to Pay $110 Million to Resolve Kentucky Opioid Lawsuit
03/13/2025
Ann W. Latner, JD
Kentucky Attorney General Russell Coleman has announced a multimillion-dollar settlement in the state’s case against Kroger. The Case The state of Kentucky alleged that Kroger helped fuel a deadly opioid epidemic by flooding communities...
Kentucky Attorney General Russell Coleman has announced a multimillion-dollar settlement in the state’s case against Kroger. The Case The state of Kentucky alleged that Kroger helped fuel a deadly opioid epidemic by flooding communities...
Kentucky Attorney General...
03/13/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Pharmacists Sent to Prison for Insurance Fraud
03/07/2025
Ann W. Latner, JD
The US Department of Justice has announced that 4 pharmacy owners have been sentenced to prison following their convictions by a federal jury for health care and wire fraud.
The US Department of Justice has announced that 4 pharmacy owners have been sentenced to prison following their convictions by a federal jury for health care and wire fraud.
The US Department of Justice has...
03/07/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Former Pharmacy Student Settles Lawsuit Against School Over Social Media Posts
02/25/2025
Ann W. Latner, JD
A fascinating case that began in 2021 has finally settled, with pharmacist Kimberly Diei receiving $250 000 from her former pharmacy school.
A fascinating case that began in 2021 has finally settled, with pharmacist Kimberly Diei receiving $250 000 from her former pharmacy school.
A fascinating case that began in...
02/25/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
CVS Responds to Justice Department Lawsuit
02/20/2025
Ann W. Latner, JD
As we wrote about last month, at the end of 2024 the US Department of Justice filed a nationwide lawsuit against pharmacy giant CVS, alleging that the chain was unlawfully dispensing massive quantities of opioids and other controlled...
As we wrote about last month, at the end of 2024 the US Department of Justice filed a nationwide lawsuit against pharmacy giant CVS, alleging that the chain was unlawfully dispensing massive quantities of opioids and other controlled...
As we wrote about last month, at...
02/20/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Insulin Pricing Lawsuit Filed by Massachusetts Attorney General
02/10/2025
Ann W. Latner, JD
Joy Campbell, Massachusetts attorney general, has filed a lawsuit against a slew of defendants, including insulin manufacturers Eli Lilly, Sanofi, Novo Nordisk, as well as pharmacy benefit managers (PBMs) Optum Rx, Express Scripts, and CVS...
Joy Campbell, Massachusetts attorney general, has filed a lawsuit against a slew of defendants, including insulin manufacturers Eli Lilly, Sanofi, Novo Nordisk, as well as pharmacy benefit managers (PBMs) Optum Rx, Express Scripts, and CVS...
Joy Campbell, Massachusetts...
02/10/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
US Department of Justice Accuses Walgreens of Unlawfully Filling Millions of Opioid Prescriptions
02/06/2025
Ann W. Latner, JD
The US Department of Justice (DOJ) has filed a nationwide lawsuit against pharmacy chain Walgreens, alleging that it dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act and sought reimbursement from...
The US Department of Justice (DOJ) has filed a nationwide lawsuit against pharmacy chain Walgreens, alleging that it dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act and sought reimbursement from...
The US Department of Justice...
02/06/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Justice Department Sues CVS for Violation of the Controlled Substances Act
01/24/2025
Ann W. Latner, JD
At the end of 2024, the US Department of Justice (DOJ) filed a huge nationwide lawsuit against CVS, alleging that the pharmacy chain knowingly dispensed controlled substances in violation of both the Controlled Substances Act and the False...
At the end of 2024, the US Department of Justice (DOJ) filed a huge nationwide lawsuit against CVS, alleging that the pharmacy chain knowingly dispensed controlled substances in violation of both the Controlled Substances Act and the False...
At the end of 2024, the US...
01/24/2025
Pharmacy Learning Network
Ann Latner Headshot
Commentary
Pharmacist Arrested for Health Care Fraud and Identity Theft
01/16/2025
Ann W. Latner, JD
A Tennessee pharmacist has been arrested and indicted on 15 charges related to a health care fraud scheme.
A Tennessee pharmacist has been arrested and indicted on 15 charges related to a health care fraud scheme.
A Tennessee pharmacist has been...
01/16/2025
Pharmacy Learning Network

Interviews

Vishali Amin
Interview
The State of Drug Affordability Programs and Reformation Solutions
01/29/2024
Vishali Amin, PharmD
In this interview, Vishali Amin, VP of Value Delivery at Kalderos, discusses the impact of drug affordability on Medicare patients and medical costs, as well as the barriers preventing patients from benefiting from existing programs, the need...
In this interview, Vishali Amin, VP of Value Delivery at Kalderos, discusses the impact of drug affordability on Medicare patients and medical costs, as well as the barriers preventing patients from benefiting from existing programs, the need...
In this interview, Vishali Amin,...
01/29/2024
Pharmacy Learning Network
Guy Headshot
Interview
Securing the Medical Supply Chain: Addressing RSV Drug Shortages With IoT-Enabled Condition Monitoring in the Health Care Industry
12/12/2023
Guy Yehiav
With the increase in supply chain shortages, Guy Yehiav offers expert insights into conditioning monitoring's impact on antibody drug dosages for RSV. 
With the increase in supply chain shortages, Guy Yehiav offers expert insights into conditioning monitoring's impact on antibody drug dosages for RSV. 
With the increase in supply...
12/12/2023
Pharmacy Learning Network
Interview
Systemic and Topical Treatments For Atopic Dermatitis
10/31/2023
Derek Chu, MD, PhD, FRCPC
In this feature interview, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview, Dr...
10/31/2023
Pharmacy Learning Network
Interview
Viewpoints on Integrative Dermatology, Part 2
10/26/2023
Sarah L. Taylor, MD, MPH, BS 
In this second installment of a series exploring integrative approaches in dermatology, Dr Sarah Taylor shares her insights from 20 years of working with alternative treatments.
In this second installment of a series exploring integrative approaches in dermatology, Dr Sarah Taylor shares her insights from 20 years of working with alternative treatments.
In this second installment of a...
10/26/2023
Pharmacy Learning Network
Interview
Viewpoints on Integrative Dermatology, Part 1
10/25/2023
Peter Lio, MD, FAAD
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking...
10/25/2023
Pharmacy Learning Network
Interview
Once-Daily, Single-Tablet Combination Therapy of Macitentan, Tadalafil in the Management of Patients With PAH
10/21/2023
James F. List, MD, PhD
In this interview, James F. List, MD, PhD, Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Janssen Research & Development, LLC, explains the A DUE study.
In this interview, James F. List, MD, PhD, Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Janssen Research & Development, LLC, explains the A DUE study.
In this interview, James...
10/21/2023
Pharmacy Learning Network
Headshot of Anita Patel, PharmD, Walgreens
Interview
Impact of COVID-19 Vaccines on Patients, Health Systems
12/21/2022
Maria Asimopoulos
Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.
Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.
Anita Patel, PharmD, vice...
12/21/2022
Integrated Healthcare Executive
Headshot of Reetu Mukherji, MD, Georgetown University
Interview
Evaluating a Digital Tool for Monitoring Drug Toxicities in Patients With Colorectal Cancer
12/12/2022
Maria Asimopoulos
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD,...
12/12/2022
Pharmacy Learning Network
Headshot of Nicole L Stout, DPT, CLT-LANA, FAPTA
Interview
Enhancing Distress Screening, Management Across Cancer Care Delivery Settings
11/23/2022
Samantha Matthews
Nicole L Stout, DPT, CLT-LANA, FAPTA, research assistant professor in the School of Medicine, Department of Hematology/Oncology, West Virginia University Cancer Institute, shares her team’s research on distress screening and a quality...
Nicole L Stout, DPT, CLT-LANA, FAPTA, research assistant professor in the School of Medicine, Department of Hematology/Oncology, West Virginia University Cancer Institute, shares her team’s research on distress screening and a quality...
Nicole L Stout, DPT, CLT-LANA,...
11/23/2022
Pharmacy Learning Network
Headshot of Safiya Karim
Interview
Discussing Association of Medical Cannabis, Prescription Opioid Use Among Patients With Cancer
10/18/2022
Edan Stanley
Safiya Karim, MD MSc FRCPC, clinical associate professor, medical oncologist, Tom Baker Cancer Centre, University of Calgary, offers insight from her team’s research on the relationship between medical cannabis and continuation of...
Safiya Karim, MD MSc FRCPC, clinical associate professor, medical oncologist, Tom Baker Cancer Centre, University of Calgary, offers insight from her team’s research on the relationship between medical cannabis and continuation of...
Safiya Karim, MD MSc FRCPC,...
10/18/2022
Pharmacy Learning Network

Podcasts

PopHealth Perspectives Stephen Crystal Part 2
PopHealth Perspectives
Addressing Prescription Drug Pricing: Fixing an Unsustainable Situation
12/28/2023
Stephen Crystal, PhD
Join us for part two of a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research...
Join us for part two of a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research...
Join us for part two of a...
12/28/2023
Pharmacy Learning Network
Crystal
Podcasts
Addressing Prescription Drug Pricing: The Urgent Need for Price Negotiation in Medicare
12/13/2023
Stephen Crystal, PhD
Join us for a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research and...
Join us for a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research and...
Join us for a conversation about...
12/13/2023
Pharmacy Learning Network
Headshot of Stephanie Ostling Mason, Glytec, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Improving Glycemic Management for Better Outcomes, Cost Savings
12/07/2022
Maria Asimopoulos
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD,...
12/07/2022
Pharmacy Learning Network
Headshot of Eric Tichy on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Drug Spending Trends: Biosimilars, COVID-19 Therapies, and More
09/28/2022
Maria Asimopoulos
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice...
09/28/2022
Integrated Healthcare Executive
Headshot of Michael Ganio, ASHP, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Monkeypox Vaccines: Current Options, Considerations for Patient Education
09/28/2022
Maria Asimopoulos
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS,...
09/28/2022
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use